J Vermylen1, M F Hoylaerts, J Arnout. Show Affiliations » 1. Center for Molecular and Vascular Biology, University of Leuven, Belgium. jozef.vermylen@med.kuleuven.ac.be
Abstract
Entities: Disease
Mesh: See more » Antibodies/bloodAntibodies, Antiphospholipid/immunologyAutoantibodies/immunologyHeparin/adverse effectsHumansLupus Coagulation Inhibitor/immunologyThrombocytopenia/chemically inducedThrombocytopenia/immunologyThrombosis/chemically inducedThrombosis/immunologyvon Willebrand Factor/immunology
Substances: See more » AntibodiesAntibodies, AntiphospholipidAutoantibodiesLupus Coagulation Inhibitorvon Willebrand FactorHeparin
Year: 1997 PMID: 9198190
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249